Order Article Reprints

Koistinen H, Boyd S, Arola J, Jokelainen K, Koistinen R, Lempiäinen A, Hotakainen K, Stenman U-H, Färkkilä M. Biliary hCGβ Is a Potential Novel Marker for Prediction of Biliary Neoplasia in Primary Sclerosing Cholangitis Patients. Livers. 2021; 1(4):322-329. https://doi.org/10.3390/livers1040025

Koistinen, Hannu, Sonja Boyd, Johanna Arola, Kalle Jokelainen, Riitta Koistinen, Anna Lempiäinen, Kristina Hotakainen, Ulf-Håkan Stenman, and Martti Färkkilä. 2021. "Biliary hCGβ Is a Potential Novel Marker for Prediction of Biliary Neoplasia in Primary Sclerosing Cholangitis Patients" Livers 1, no. 4: 322-329. https://doi.org/10.3390/livers1040025

Koistinen, H., Boyd, S., Arola, J., Jokelainen, K., Koistinen, R., Lempiäinen, A., Hotakainen, K., Stenman, U.-H., & Färkkilä, M. (2021). Biliary hCGβ Is a Potential Novel Marker for Prediction of Biliary Neoplasia in Primary Sclerosing Cholangitis Patients. Livers, 1(4), 322-329. https://doi.org/10.3390/livers1040025